A117 (Zolpidem tartrate extended release 6.25 mg)

Pill imprint A117 has been identified as Zolpidem tartrate extended release 6.25 mg.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for A117

Zolpidem tartrate extended release 6.25 mg A117
Zolpidem tartrate extended release 6.25 mg A117
Zolpidem tartrate extended release
Imprint:
A117
Strength:
6.25 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Anchen Pharmaceuticals Inc.
National Drug Code (NDC):
10370-0117
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
polyethylene glycol
sucrose
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
polyvinyl alcohol
magnesium silicate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)